studied life science management in Berlin and works as a team leader in the Value & Access Strategy department at the IGES Institute. His focus is on questions about reimbursement pricing instruments in the various sectors of the German healthcare system with regard to innovative medicines. He is also responsible for data analyzes and modeling to map care structures for patients in the statutory health insurance system.